![1-in-5 Prescriptions Are Off-Label: What You Don't Know Could Hurt You | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy 1-in-5 Prescriptions Are Off-Label: What You Don't Know Could Hurt You | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy](https://images.prismic.io/medtruth/6a1a6e92-33e8-45e8-9ea9-5c2139c92d36_offlabel-RXpad.png?auto=compress,format)
1-in-5 Prescriptions Are Off-Label: What You Don't Know Could Hurt You | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy
![Use of Booklet Labels on Investigational Medicinal Products (IMPs) | ISPE | International Society for Pharmaceutical Engineering Use of Booklet Labels on Investigational Medicinal Products (IMPs) | ISPE | International Society for Pharmaceutical Engineering](https://ispe.org/sites/default/files/styles/guidance_document_image/public/magazine/use-of-booklet-labels-investigational-medicinal-products.png?itok=RGXnlIHe)
Use of Booklet Labels on Investigational Medicinal Products (IMPs) | ISPE | International Society for Pharmaceutical Engineering
![Deciphera details stomach cancer flop against Pfizer's Sutent, cracking the door open for off-label use | FiercePharma Deciphera details stomach cancer flop against Pfizer's Sutent, cracking the door open for off-label use | FiercePharma](https://qtxasset.com/fiercepharma/1643127366/DoorCrackOpen.jpg?VersionId=36Ev0Ghx7KncE2kG.qnMQM6TCb7Isrhz)
Deciphera details stomach cancer flop against Pfizer's Sutent, cracking the door open for off-label use | FiercePharma
![Off-label use of medicines: consensus recommendations for evaluating appropriateness | The Medical Journal of Australia Off-label use of medicines: consensus recommendations for evaluating appropriateness | The Medical Journal of Australia](https://www.mja.com.au/sites/default/files/issues/185_10_201106/gaz10250_fm-1.gif)
Off-label use of medicines: consensus recommendations for evaluating appropriateness | The Medical Journal of Australia
![Off-label use in Palliative Care – more common than expected. A retrospective chart review | medRxiv Off-label use in Palliative Care – more common than expected. A retrospective chart review | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/01/20/2021.01.17.21249962/F1.large.jpg)
Off-label use in Palliative Care – more common than expected. A retrospective chart review | medRxiv
![Off‐label drug use in oncology: a systematic review of literature - Saiyed - 2017 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Off‐label drug use in oncology: a systematic review of literature - Saiyed - 2017 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f5e65eff-4166-4dfc-9d1e-996b643e16f1/jcpt12507-fig-0001-m.jpg)